176 related articles for article (PubMed ID: 24893995)
1. Preparation and characterization of rivastigmine loaded human serum albumin (HSA) nanoparticles.
Avachat AM; Oswal YM; Gujar KN; Shah RD
Curr Drug Deliv; 2014; 11(3):359-70. PubMed ID: 24893995
[TBL] [Abstract][Full Text] [Related]
2. Rivastigmine-loaded PLGA and PBCA nanoparticles: preparation, optimization, characterization, in vitro and pharmacodynamic studies.
Joshi SA; Chavhan SS; Sawant KK
Eur J Pharm Biopharm; 2010 Oct; 76(2):189-99. PubMed ID: 20637869
[TBL] [Abstract][Full Text] [Related]
3. Preparation, characterization and targeting of micronized 10-hydroxycamptothecin-loaded folate-conjugated human serum albumin nanoparticles to cancer cells.
Li Q; Liu C; Zhao X; Zu Y; Wang Y; Zhang B; Zhao D; Zhao Q; Su L; Gao Y; Sun B
Int J Nanomedicine; 2011; 6():397-405. PubMed ID: 21499429
[TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity.
Kim TH; Jiang HH; Youn YS; Park CW; Tak KK; Lee S; Kim H; Jon S; Chen X; Lee KC
Int J Pharm; 2011 Jan; 403(1-2):285-91. PubMed ID: 21035530
[TBL] [Abstract][Full Text] [Related]
5. Preparation and Evaluation of in vitro Self-assembling HSA Nanoparticles for Cabazitaxel.
Qu N; Sun Y; Xie J; Teng L
Anticancer Agents Med Chem; 2017; 17(2):294-300. PubMed ID: 27225451
[TBL] [Abstract][Full Text] [Related]
6. Docetaxel-loaded human serum albumin (HSA) nanoparticles: synthesis, characterization, and evaluation.
Qu N; Sun Y; Li Y; Hao F; Qiu P; Teng L; Xie J; Gao Y
Biomed Eng Online; 2019 Jan; 18(1):11. PubMed ID: 30704488
[TBL] [Abstract][Full Text] [Related]
7. Preparation and optimization of rivastigmine-loaded tocopherol succinate-based solid lipid nanoparticles.
Malekpour-Galogahi F; Hatamian-Zarmi A; Ganji F; Ebrahimi-Hosseinzadeh B; Nojoki F; Sahraeian R; Mokhtari-Hosseini ZB
J Liposome Res; 2018 Sep; 28(3):226-235. PubMed ID: 28670949
[TBL] [Abstract][Full Text] [Related]
8. Interaction of folate-conjugated human serum albumin (HSA) nanoparticles with tumour cells.
Ulbrich K; Michaelis M; Rothweiler F; Knobloch T; Sithisarn P; Cinatl J; Kreuter J
Int J Pharm; 2011 Mar; 406(1-2):128-34. PubMed ID: 21185364
[TBL] [Abstract][Full Text] [Related]
9. Rational design of polysorbate 80 stabilized human serum albumin nanoparticles tailored for high drug loading and entrapment of irinotecan.
Taneja N; Singh KK
Int J Pharm; 2018 Jan; 536(1):82-94. PubMed ID: 29146538
[TBL] [Abstract][Full Text] [Related]
10. A toolbox for the upscaling of ethanolic human serum albumin (HSA) desolvation.
Wacker M; Zensi A; Kufleitner J; Ruff A; Schütz J; Stockburger T; Marstaller T; Vogel V
Int J Pharm; 2011 Jul; 414(1-2):225-32. PubMed ID: 21571055
[TBL] [Abstract][Full Text] [Related]
11. Pyrazolo[3,4-d]pyrimidines-loaded human serum albumin (HSA) nanoparticles: Preparation, characterization and cytotoxicity evaluation against neuroblastoma cell line.
Fallacara AL; Mancini A; Zamperini C; Dreassi E; Marianelli S; Chiariello M; Pozzi G; Santoro F; Botta M; Schenone S
Bioorg Med Chem Lett; 2017 Jul; 27(14):3196-3200. PubMed ID: 28558969
[TBL] [Abstract][Full Text] [Related]
12. Carboplatin loaded Surface modified PLGA nanoparticles: Optimization, characterization, and in vivo brain targeting studies.
Jose S; Juna BC; Cinu TA; Jyoti H; Aleykutty NA
Colloids Surf B Biointerfaces; 2016 Jun; 142():307-314. PubMed ID: 26970818
[TBL] [Abstract][Full Text] [Related]
13. Design and evaluation of chitosan nanoparticles as novel drug carrier for the delivery of rivastigmine to treat Alzheimer's disease.
Wilson B; Samanta MK; Muthu MS; Vinothapooshan G
Ther Deliv; 2011 May; 2(5):599-609. PubMed ID: 22833977
[TBL] [Abstract][Full Text] [Related]
14. Pharmaceutical potential of tacrolimus-loaded albumin nanoparticles having targetability to rheumatoid arthritis tissues.
Thao le Q; Byeon HJ; Lee C; Lee S; Lee ES; Choi HG; Park ES; Youn YS
Int J Pharm; 2016 Jan; 497(1-2):268-76. PubMed ID: 26657273
[TBL] [Abstract][Full Text] [Related]
15. Doxorubicin-loaded nanoparticles consisted of cationic- and mannose-modified-albumins for dual-targeting in brain tumors.
Byeon HJ; Thao le Q; Lee S; Min SY; Lee ES; Shin BS; Choi HG; Youn YS
J Control Release; 2016 Mar; 225():301-13. PubMed ID: 26826308
[TBL] [Abstract][Full Text] [Related]
16. Human serum albumin (HSA) nanoparticles: reproducibility of preparation process and kinetics of enzymatic degradation.
Langer K; Anhorn MG; Steinhauser I; Dreis S; Celebi D; Schrickel N; Faust S; Vogel V
Int J Pharm; 2008 Jan; 347(1-2):109-17. PubMed ID: 17681686
[TBL] [Abstract][Full Text] [Related]
17. A comparative and systematic approach to desolvation and self-assembly methods for synthesis of piperine-loaded human serum albumin nanoparticles.
Abolhassani H; Shojaosadati SA
Colloids Surf B Biointerfaces; 2019 Dec; 184():110534. PubMed ID: 31627104
[TBL] [Abstract][Full Text] [Related]
18. In situ-forming oleogel implant for rivastigmine delivery.
Vintiloiu A; Lafleur M; Bastiat G; Leroux JC
Pharm Res; 2008 Apr; 25(4):845-52. PubMed ID: 17694395
[TBL] [Abstract][Full Text] [Related]
19. Doxorubicin-Bound Albumin Nanoparticles Containing a TRAIL Protein for Targeted Treatment of Colon Cancer.
Thao le Q; Byeon HJ; Lee C; Lee S; Lee ES; Choi YW; Choi HG; Park ES; Lee KC; Youn YS
Pharm Res; 2016 Mar; 33(3):615-26. PubMed ID: 26526555
[TBL] [Abstract][Full Text] [Related]
20. Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting.
Fazil M; Md S; Haque S; Kumar M; Baboota S; Sahni JK; Ali J
Eur J Pharm Sci; 2012 Aug; 47(1):6-15. PubMed ID: 22561106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
